GlassScriptPhysician profile
Beatrice Chaicharncheep
NPI 1083875868
$6,102.37
in general payments reported to CMS, 2019-2025
21 companies · $1,086 in 2025
The $1,086 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,510 · 2020: $185 · 2021: $328 · 2022: $1,146 · 2023: $974 · 2024: $873 · 2025: $1,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,933.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,787.62 | 2023-2025 | Botox, Dalvance |
| Smith+Nephew, INC. | $992.35 | 2019-2023 | Grafix, Oasis |
| Galderma Laboratories, L.P. | $534.40 | 2019-2023 | Dysport |
| Merz North America, INC. | $467.65 | 2021-2025 | |
| Organogenesis INC. | $454.77 | 2019-2025 | Puraply, Apligraf |
| Osiris Therapeutics INC. | $331.12 | 2019 | |
| Allergan, INC. | $239.72 | 2022 | |
| Ossur Americas, INC. | $204.72 | 2024-2025 | |
| Cumberland Pharmaceuticals, INC. | $197.31 | 2019-2022 | |
| Kerecis Limited | $167.27 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Paratek Pharmaceuticals, INC. | $126.94 | 2021-2024 | Nuzyra |
| Urgo Medical North America, LLC | $123.46 | 2023-2025 | Urgoclean Ag, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Medela LLC | $119.53 | 2024 | Invia Motion Endure |
| Solventum Corporation | $98.59 | 2024 | V.A.C. Veraflo |
| Integra Lifesciences Corporation | $88.07 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $65.37 | 2019-2025 | Orbactiv, Kimyrsa |
| Kci USA, INC. | $34.70 | 2020-2023 | Activ.A.C. |
| Bsn Medical INC | $23.54 | 2022 | |
| Tactile Systems Technology INC | $17.32 | 2023 | Entre Plus, Flexitouch Plus |
| Aroa Biosurgery Incorporated | $14.59 | 2025 | |
| Currax Pharmaceuticals LLC | $13.33 | 2023 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beatrice Chaicharncheep listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.